GS
RETA

GTS Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

GTS Securities’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,833
Closed -$799K – 2056
2023
Q2 		$799K Buy
+7,833
New +$799K 0.03% 498